Growing Concern Over Catheter Related Blood Stream Infections

 Impact on Healthcare Industry

Catheter related bloodstream infections (CRBSIs) have been a longtime challenge for hospitals and healthcare facilities. These infections not only cause harm to patients but also result in increased costs, extended hospital stays and loss of revenue for providers. With rising cases of CRBSIs being reported across the country, it is becoming a serious issue affecting the healthcare industry.

Rising Infection Rates

Data from the Centers for Disease Control and Prevention shows that CRBSIs account for over 250,000 cases annually in the United States. This translates to around one infection for every 1,000 catheter days. Several studies have found the infection rates to be higher for patients in intensive care units who require central lines for extended periods. The frequency of CRBSIs has seen an upward trend over the past decade due to growing antibiotic resistance and increasing risk factors like aging population and complicated medical procedures. If left unaddressed, experts warn that the rates could continue climbing in the coming years.

Financial Burden on Hospitals

Treating patients with CRBSIS places a huge financial strain on hospitals. It is estimated that the excess costs associated with each infection ranges between $33,000 to $56,000. This includes additional antimicrobial use, invasive procedures for diagnosis and treatment, prolonged hospitalization and increased nursing care. Multiplying these costs by the large number of cases reported annually results in an economic burden of over $5 billion for US healthcare facilities. Some studies have also found that hospitals may lose up to $70,000 or more in reimbursements and penalties due to health care-associated infections.

Impact on Hospital Reimbursement

The rising CRBSI rates not only increase treatment expenses for hospitals but also affect their reimbursement. The Centers for Medicare and Medicaid Services have implemented various policies to reduce payment to hospitals that have high rates of certain avoidable healthcare-acquired conditions like central line-associated bloodstream infections. These non-payment penalties coupled with bundled payment models are putting more financial pressure on institutions. Many private payers have also adopted a similar approach by denying additional payments for treating infections acquired during hospital stay. This financial disincentive is forcing hospitals to invest more in infection control measures to curb CRBSIs.

Improving Prevention Strategies

To combat the growing problem of CRBSIs, healthcare facilities have stepped up prevention efforts through multifaceted strategies. This involves dedicated vascular access teams for line insertion and maintenance, use of antiseptic contaminated devices and maximal sterile barrier precautions during insertion. Hospitals are also focusing on staff education and adherence to evidence-based guidelines published by CDC for optimal catheter care and prompt removal of unnecessary lines. Some have implemented checklists, reminders and electronic surveillance tools to monitor compliance. While these measures have shown success in reducing CRBSI rates, sustained efforts are needed to further curb infections and their economic impact on the industry.

Investment in New Technologies

Beyond traditional prevention tactics, hospitals are investing in novel technologies to minimize the risk of CRBSIs. This includes sterile coated catheters that prevent bacterial colonization on the catheter surface as well as antimicrobial impregnated central venous catheters and connectors. Use of antimicrobial dressings, needleless systems and disinfectant caps also help maintain the sterility of invasive devices. More US hospitals are proactively adopting these advanced products, despite the higher upfront costs, to curb the growing economic burden in the long run. Researchers are also exploring technologies like intravenous robotics, medical imaging and big data analytics to further enhance prevention efforts.

Challenges Persist

Despite raising awareness and allocating more resources towards prevention, complete elimination of CRBSIs remains challenging. Areas like intensive care units dealing with high-risk patients still report significant infection rates. Limited durability of some novel technologies and lack of multi-drug resistant organism decontamination also impede progress. Ensuring consistent compliance to protocols among busy clinical staff remains an ongoing task. Restricted hospital budgets also deter rapid adoption of costly equipment. Regulatory agencies continue enhancing policies to incentivize quality improvement and assuage the financial impact of infections through value-based payment models. With collaborative efforts, it is hoped that CRBSI rates can be lowered substantially in the coming years saving both lives and healthcare dollars.

 

 

Get More Insights On Catheter Related Blood Stream Infections